The number of people with susceptibility test result for rifampicin in Bulgaria
Bulgaria: The number of people with susceptibility test result for rifampicin was 156 in 2021. ▼ Falling
Latest (2021)
156
Change on year
down 24.6%
World rank
100th
of 155 countries
All-time high
524
in 2017
All-time low
156
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bulgaria, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Bulgaria is 156, measured in 2021. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 24.6% on the previous year and down 70.2% over five years.
That places Bulgaria 100th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Bulgaria, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 524 | — |
| 2018 | 476 | -9.2% |
| 2019 | 403 | -15.3% |
| 2020 | 207 | -48.6% |
| 2021 | 156 | -24.6% |
Bulgaria compared with similar countries
- Bulgaria's 156 is above the median for high income countries, which is 142, 1.1× the median. (61 countries reporting)
- Bulgaria's 156 is below the median for Europe & Central Asia, which is 229.5, 68% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 467.67 | 403 | 524 | 3 |
| 2020s | 181.5 | 156 | 207 | 2 |
Countries ranked near Bulgaria
More health data for Bulgaria
- Un projection of annual infant deaths, annual growth rate -2.5 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.615 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,422 deaths per 1,000 people (2090)
- Number of infants who die before age 1 39 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2564 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.3643 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bulgaria?
- The number of people with susceptibility test result for rifampicin in Bulgaria was 156 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bulgaria?
- The highest recorded value was 524 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bulgaria?
- The lowest recorded value was 156 in 2021.
- How does Bulgaria rank for the number of people with susceptibility test result for rifampicin?
- Bulgaria ranks 100th out of 155 countries with data for 2021.
- Where does this Bulgaria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).